Received Jun 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
he was vaccinated with his first dose of Shingrix in July 2024; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose in July 2024). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: he was vaccinated with his first dose of Shingrix in July 2024). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 12-JUN-2025 The consumer (patient) was the reporter. The consumer mentioned that he was vaccinated with his first dose of Shingrix in July 2024. The consumer does plan to have his second dose administered as soon as possible. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.